Trials / Completed
CompletedNCT01935869
Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 224 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the skin irritation potential and sensitisation potential of LEO 90100 and the vehicle after repeated applications on the skin of healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 90100 | |
| DRUG | Vehicle | |
| DRUG | Petrolatum ointment |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-11-01
- Completion
- 2013-12-01
- First posted
- 2013-09-05
- Last updated
- 2025-02-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01935869. Inclusion in this directory is not an endorsement.